摘要:
Novel human interleukin-2 (IL-2) muteins or variants thereof, and nucleic acid molecules and variants thereof are provided. Methods for producing these muteins as well as methods for stimulating the immune system of an animal are also disclosed. In addition, the invention provides recombinant expression vectors comprising the nucleic acid molecules of this invention and host cells into which expression vectors have been introduced. Pharmaceutical compositions are included comprising a therapeutically effective amount of a human IL-2 mutein of the invention and a pharmaceutically acceptable carrier. The IL-2 muteins can be used in pharmaceutical compositions for use in treatment of cancer and in stimulating the immune response.
摘要:
A system, computer-readable storage medium storing at least one program, and a computer-implemented method for controlling a local utility are disclosed. A first request originating from an application and including a first token is received at a local utility. The application received a web page, including a plurality of links and the first token, from a first server. The plurality of links are received by the application from a second server. The first token is authenticated. Authentication includes sending the first token to a third server. In response to authenticating the first token, a second token is generated at the local utility. The second token is sent to the application for inclusion in subsequent requests from the application.
摘要:
Novel human interleukin-2 (IL-2) muteins or variants thereof, and nucleic acid molecules and variants thereof are provided. Methods for producing these muteins as well as methods for stimulating the immune system of an animal are also disclosed. In addition, the invention provides recombinant expression vectors comprising the nucleic acid molecules of this invention and host cells into which expression vectors have been introduced. Pharmaceutical compositions are included comprising a therapeutically effective amount of a human IL-2 mutein of the invention and a pharmaceutically acceptable carrier. The IL-2 muteins can be used in pharmaceutical compositions for use in treatment of cancer and in stimulating the immune response.
摘要:
A system, computer-readable storage medium storing at least one program, and a computer-implemented method for controlling a local utility are disclosed. A first request originating from an application and including a first token is received at a local utility. The application received a web page, including a plurality of links and the first token, from a first server. The plurality of links are received by the application from a second server. The first token is authenticated. Authentication includes sending the first token to a third server. In response to authenticating the first token, a second token is generated at the local utility. The second token is sent to the application for inclusion in subsequent requests from the application.